Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. (Q37833892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

review article

1 reference

title

Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Kyle L Kolaja

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

111-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrd3252

21 January 2020

exact match

0 references

cites work

The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture.

1 reference

Exploring sequence-structure relationships in the tyrosine kinome space: functional classification of the binding specificity mechanisms for cancer therapeutics.

21 January 2018

1 reference

Kinases as targets in the treatment of solid tumors.

21 January 2018

1 reference

Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors.

21 January 2018

1 reference

Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics.

21 January 2018

1 reference

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials

21 January 2018

1 reference

Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.

21 January 2018

1 reference

A general strategy for creating "inactive-conformation" abl inhibitors

21 January 2018

1 reference

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

Targeting cancer with small molecule kinase inhibitors

21 January 2018

1 reference

Selectively nonselective kinase inhibition: striking the right balance

21 January 2018

1 reference

VEGF kinase inhibitors: how do they cause hypertension?

21 January 2018

1 reference

Targeting the phosphoinositide 3-kinase pathway in cancer

21 January 2018

1 reference

Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo

21 January 2018

1 reference

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

21 January 2018

1 reference

The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart.

21 January 2018

1 reference

Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase

21 January 2018

1 reference

VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium

21 January 2018

1 reference

Heterozygous disruption of Flk-1 receptor leads to myocardial ischaemia reperfusion injury in mice: application of affymetrix gene chip analysis

21 January 2018

1 reference

Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress.

21 January 2018

1 reference

Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload

21 January 2018

1 reference

Cardiotoxicity induced by tyrosine kinase inhibitors

21 January 2018

1 reference

A quantitative analysis of kinase inhibitor selectivity

21 January 2018

1 reference

Hypoxia-induced energy stress regulates mRNA translation and cell growth

21 January 2018

1 reference

Activation of AMPK is necessary for killing cancer cells and sparing cardiac cells

21 January 2018

1 reference

Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma.

21 January 2018

1 reference

Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.

21 January 2018

1 reference

Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24.

21 January 2018

1 reference

The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity

21 January 2018

1 reference

A small molecule-kinase interaction map for clinical kinase inhibitors

21 January 2018

1 reference

Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors

21 January 2018

1 reference

Evidence for cardiomyocyte renewal in humans

21 January 2018

1 reference

Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction

21 January 2018

1 reference

Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function

21 January 2018

1 reference

Cardiac stem cells and myocardial disease

21 January 2018

1 reference

Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice

21 January 2018

1 reference

Exposure to anthracyclines during childhood causes cardiac injury

21 January 2018

1 reference

c-kit is required for cardiomyocyte terminal differentiation

21 January 2018

1 reference

ErbB2 is essential in the prevention of dilated cardiomyopathy.

21 January 2018

1 reference

Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload

21 January 2018

1 reference

PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.

21 January 2018

1 reference

p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload

21 January 2018

1 reference

With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure

21 January 2018

1 reference

Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery

21 January 2018

1 reference

Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

Circumventing the Crabtree Effect: Replacing Media Glucose with Galactose Increases Susceptibility of HepG2 Cells to Mitochondrial Toxicants

21 January 2018

1 reference

Properties of a clonal muscle cell line from rat heart

21 January 2018

1 reference

Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway

21 January 2018

1 reference

Time-dependent block of ultrarapid-delayed rectifier K+ currents by aconitine, a potent cardiotoxin, in heart-derived H9c2 myoblasts and in neonatal rat ventricular myocytes

21 January 2018

1 reference

Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells

21 January 2018

1 reference

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

21 January 2018

1 reference

Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

Functional cardiomyocytes derived from human induced pluripotent stem cells

21 January 2018

1 reference

Electromechanical integration of cardiomyocytes derived from human embryonic stem cells.

21 January 2018

1 reference

Calcium handling in human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications

21 January 2018

1 reference

Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening

21 January 2018

1 reference

Zebrafish as a model vertebrate for investigating chemical toxicity

21 January 2018

1 reference

Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation

21 January 2018

1 reference

Defective "pacemaker" current (Ih) in a zebrafish mutant with a slow heart rate

21 January 2018

1 reference

The most transparent research

21 January 2018

1 reference

An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic

21 January 2018

1 reference

Concordance of the toxicity of pharmaceuticals in humans and in animals

21 January 2018

1 reference

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology

21 January 2018

1 reference

A new season for cardiac troponin assays: it's time to keep a scorecard.

21 January 2018

1 reference

High-sensitivity cardiac troponin assays: what analytical and clinical issues need to be addressed before introduction into clinical practice? Interview by Fred S. Apple.

21 January 2018

1 reference

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition

21 January 2018

1 reference

Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation

21 January 2018

1 reference

New developments in anthracycline-induced cardiotoxicity.

21 January 2018

1 reference

Application of metabolomics to cardiovascular biomarker and pathway discovery

21 January 2018

1 reference

Metabolic signatures of exercise in human plasma

21 January 2018

1 reference

A decade of discoveries in cardiac biology

21 January 2018

1 reference

Calcium pumps in health and disease

21 January 2018

1 reference

Molecular regulation of cardiac hypertrophy

21 January 2018

1 reference

Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.

21 January 2018

1 reference

CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses

21 January 2018

1 reference

Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice

21 January 2018

1 reference

Phospholamban phosphorylation by CaMKII under pathophysiological conditions

21 January 2018

1 reference

Selectivity and therapeutic inhibition of kinases: to be or not to be?

21 January 2018

1 reference

Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice

21 January 2018

1 reference

Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia

21 January 2018

1 reference

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling

21 January 2018

1 reference

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

21 January 2018

1 reference

Imatinib mesilate inhibits neointimal hyperplasia via growth inhibition of vascular smooth muscle cells in a rat model of balloon injury

21 January 2018

1 reference

Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction.

21 January 2018

1 reference

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

21 January 2018

1 reference

Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.

21 January 2018

1 reference

Genetic approaches for changing the heart and dissecting complex syndromes

21 January 2018

1 reference

The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders

21 January 2018

1 reference

Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis

21 January 2018

1 reference

PI3K(p110alpha) inhibitors as anti-cancer agents: minding the heart.

21 January 2018

1 reference

Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy

21 January 2018

1 reference

Altered heart rate and sinoatrial node function in mice lacking the cAMP regulator phosphoinositide 3-kinase-gamma

21 January 2018

1 reference

Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.

21 January 2018

1 reference

The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease

21 January 2018

1 reference

Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia

21 January 2018

1 reference

Akt2 regulates cardiac metabolism and cardiomyocyte survival

21 January 2018

1 reference

mTOR pathway as a target in tissue hypertrophy.

21 January 2018

1 reference

The mTOR pathway: a new target in cancer therapy.

21 January 2018

1 reference

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

21 January 2018

1 reference

AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice

21 January 2018

1 reference

Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload

21 January 2018

1 reference

Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation

21 January 2018

1 reference

Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo

21 January 2018

1 reference

Mice thrive without Cdk4 and Cdk2.

21 January 2018

1 reference

Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury

21 January 2018

1 reference

Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system.

21 January 2018

1 reference

Cell cycle kinases as therapeutic targets for cancer

21 January 2018

1 reference

Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics.

21 January 2018

1 reference

Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

21 January 2018

1 reference

The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy

21 January 2018

1 reference

Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function

21 January 2018

1 reference

Experimental membranous nephropathy redux

21 January 2018

1 reference

PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose

21 January 2018

1 reference

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

21 January 2018

1 reference

STAT3-mediated activation of myocardial capillary growth

21 January 2018

1 reference

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

Role of the JAK-STAT pathway in myocardial injury

21 January 2018

1 reference

Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice

21 January 2018

1 reference

Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy

21 January 2018

1 reference

Heart-specific activation of LTK results in cardiac hypertrophy, cardiomyocyte degeneration and gene reprogramming in transgenic mice

21 January 2018

1 reference

ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice

21 January 2018

1 reference

Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction

21 January 2018

1 reference

Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death.

21 January 2018

1 reference

A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy

21 January 2018

1 reference

MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.

21 January 2018

1 reference

Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy

21 January 2018

1 reference

Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome

21 January 2018

1 reference

Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach

21 January 2018

1 reference

Pim-1 regulates cardiomyocyte survival downstream of Akt.

21 January 2018

1 reference

Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure

21 January 2018

1 reference

Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.

21 January 2018

1 reference

Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction

21 January 2018

1 reference

Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart

21 January 2018

1 reference

Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling

21 January 2018

1 reference

Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy

21 January 2018

1 reference

Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart

21 January 2018

1 reference

H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart

21 January 2018

1 reference

Distinct organization of energy metabolism in HL-1 cardiac cell line and cardiomyocytes

21 January 2018

1 reference

A cell-based sensor system for toxicity testing using multiwavelength fluorescence spectroscopy

21 January 2018

1 reference

Controllable expansion of primary cardiomyocytes by reversible immortalization

21 January 2018

1 reference

Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat.

21 January 2018

1 reference

Functional properties of K+ currents in adult mouse ventricular myocytes

21 January 2018

1 reference

Novel cell lines derived from adult human ventricular cardiomyocytes

21 January 2018

1 reference

GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice

21 January 2018

1 reference

Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform.

21 January 2018

1 reference

Primary Culture of Human Atrial Myocytes is Associated with the Appearance of Structural and Functional Characteristics of Immature Myocardium

21 January 2018

1 reference

Hypertension as a predictive factor of Sunitinib activity

21 January 2018

1 reference

Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development

31 March 2020

1 reference

Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines

31 March 2020

1 reference

Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol

31 March 2020

1 reference

The use of in vivo zebrafish assays in drug toxicity screening

31 March 2020

1 reference

Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbits

31 March 2020

1 reference

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

31 March 2020

1 reference

Effect of Exercise on Cardiac Output, Left Coronary Flow and Myocardial Metabolism in the Unanesthetized Dog

31 March 2020

1 reference

Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice

31 March 2020

1 reference

Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate

31 March 2020

1 reference

Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy

31 March 2020

1 reference

Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction

31 March 2020

1 reference

Akt1 is required for physiological cardiac growth

31 March 2020

1 reference

Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis

31 March 2020

1 reference

PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.

31 March 2020

1 reference

Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice

31 March 2020

1 reference

Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes

31 March 2020

1 reference

Rapid ventricular repolarization in rodents: electrocardiographic manifestations, molecular mechanisms, and clinical insights

31 March 2020

1 reference

Longevity of adult ventricular rat heart muscle cells in serum-free primary culture

31 March 2020

1 reference

Long-term primary cultures of human adult atrial cardiac myocytes: cell viability, structural properties and BNP secretion in vitro

31 March 2020

1 reference

Human pediatric and adult ventricular cardiomyocytes in culture: assessment of phenotypic changes with passaging

31 March 2020

1 reference

Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function

31 March 2020

1 reference

12 December 2020

Retro-orbital injection in adult zebrafish

1 reference

12 December 2020

Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis

1 reference

12 December 2020

Troponin I as a marker of doxorubicin induced cardiotoxicity.

1 reference

12 December 2020

Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog

1 reference

12 December 2020

Adult rat ventricular myocytes cultured in defined medium: phenotype and electromechanical function

1 reference

12 December 2020

Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice

1 reference

12 December 2020

Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle

1 reference

12 December 2020

Echocardiography in the assessment of heart failure

1 reference

12 December 2020

Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure

1 reference

12 December 2020

Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity.

1 reference

12 December 2020

Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits

1 reference

12 December 2020

Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRD3252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21283106%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference